BCL2 and diabetic retinopathy: MiR-21 is broadly related to metabolic disorders, e.g., CVD, diabetic retinopathy, kidney fibrosis, atherosclerotic plaques, and β-cell apoptosis, and it has been shown to influence Bcl-2 in type 1 diabetes in vivo models [217,218,219,220,221].